| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.05. | Karyopharm Therapeutics Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | Karyopharm announces significant refinancing transactions | 4 | Seeking Alpha | ||
| 08.05. | Karyopharm Therapeutics Inc reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
| 08.05. | Karyopharm Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Karyopharm Therapeutics GAAP EPS of -$0.32 beats by $0.03, revenue of $33.13M misses by $1.34M | 1 | Seeking Alpha | ||
| 08.05. | Karyopharm Therapeutics Inc.: Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress | 229 | PR Newswire | - Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into 2028 and 2029, Well Beyond Expected Data Readouts... ► Artikel lesen | |
| 01.04. | Karyopharm Therapeutics Inc.: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 72 | PR Newswire | NEWTON, Mass., April 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company... ► Artikel lesen | |
| 01.03. | Karyopharm Therapeutics Inc.: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 423 | PR Newswire | NEWTON, Mass., March 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company... ► Artikel lesen | |
| 01.03. | Karyopharm Therapeutics Inc. (KPTI) Q4 2023 Earnings Call Transcript | 6 | Insider Monkey | ||
| 01.03. | Earnings call: Karyopharm projects steady growth in cancer drug trials | 11 | Investing.com | ||
| 29.02. | Karyopharm Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 4 | Reuters | ||
| 29.02. | Karyopharm Therapeutics Inc. Q4 Loss Misses Estimates | 4 | RTTNews | ||
| 29.02. | Karyopharm Therapeutics Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 29.02. | Karyopharm Therapeutics Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.02. | Karyopharm Therapeutics Inc.: Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress | 404 | PR Newswire | - Total Revenue of $146 Million and U.S. XPOVIO® (selinexor) Net Product Revenue of $112 Million for Full Year 2023, Meeting Company's Guidance -
- Top-Line Data Readouts from Three Pivotal Phase... ► Artikel lesen | |
| 28.02. | Karyopharm Therapeutics' Earnings: A Preview | 3 | Benzinga.com | ||
| 20.02. | Karyopharm Therapeutics Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 08.01. | Karyopharm Therapeutics rises on job cuts | 17 | Reuters | ||
| 08.01. | Karyopharm expects FY total revenue to be ~$145.9 million | 15 | Seeking Alpha | ||
| 08.01. | Karyopharm Therapeutics Inc. - 8-K, Current Report | 3 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 2.904 |
| EVOTEC | 2.615 |
| TUI | 1.818 |
| NEL | 1.663 |
| NVIDIA | 1.269 |
| PLUG POWER | 1.251 |
| BAYER | 1.220 |
| AMC ENTERTAINMENT | 1.213 |
| SIEMENS ENERGY | 1.172 |
| RHEINMETALL | 1.026 |
| DEUTSCHE BANK | 943 |
| SIEMENS | 909 |
| AIXTRON SE | 832 |
| COMMERZBANK | 797 |
| DEUTSCHE TELEKOM | 771 |
| ALIBABA | 748 |
| HEIDELBERGER DRUCK | 716 |
| BYD | 687 |
| RENK GROUP | 681 |
| MERCEDES-BENZ | 679 |
| SUPER MICRO COMPUTER | 677 |
| VOLKSWAGEN | 614 |
| ALLIANZ | 592 |
| RWE | 582 |
| BMW | 563 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
